The endothelium consists of a single-layered, non-cornifying squamous epithelium that lines the heart, blood and lymph vessels and acts as a selective barrier between the blood stream and the vessel wall for dissolved substances, macromolecules and cells. The endothelium actively controls the exchange between vascular lumen and interstitium. The endothelium plays a prominent role in the formation of wall-standing thrombi. This is especially true after endothelial integrity has been compromised.
Endothelial factors with thrombogenic:
Thromboplastin( calledfactor III or tissue factor), an important activator of plasmatic coagulation from the subendothelium
PAF (Platelet activator factor)
Factor XIV (high-molecular-weight-kininogen, HMWK, also called Fitzgerald factor)
Collagen
Plasminogen activator inhibitor-1 (PAI-1) = inhibitor of fribrinolysis.
The endothelium expresses receptors for:
The HMWK
The Tenase
The prothrombinase
The factors IX and X
The von Willebrand factor
The Fibrinogen
Via these receptors, the corresponding factors bind to the endothelium at the site of the lesion. The endothelium also binds fibrinogen, fibronectin and thrombin.
Endothelial factors with antithrombotic function:
In parallel to the thrombotic endothelial factors, antithrombotic mediators are also synthesized and activated in the endothelium:
tissue factor pathway inhibitor (TFPI)
Tissue plasminogen activator (t-PA), is synthesized and secreted in the endothelium
Nitrogen monoxide (NO) = Anti-aggregation
Prostacyclin (PGI2), which has an antiaggregatory effect and is stimulated by thrombin and noradrenalin, inhibits platelet activation
ADPase, inhibits the activator ADP, a central stimulator of platelet aggregation
Thrombomodulin which binds thrombin, thus changing its enzymatic specificity and thereby activating protein C
Protein S (cofactor of protein C)
Vasodilator-stimulated phosphoprotein
A further function for the anticoagulant effect of the endothelium results from the expression of receptors for:
- protein C
Antithrombin III